Welcome to 2nd Annual Therapeutic Strategies Against Neurodegenerative Conditions

Venue: Washington DC

Location: Washington DC, United States

Event Date/Time: Apr 05, 2006
Report as Spam

Description

Santosh R. D'Mello, Ph.D.
CONFERENCE CHAIR
Professor, Dept of Molecular & Cell Biology
University of Texas at Dallas


Marcelle Bergeron,
CONFERENCE CO-CHAIR
Amgen


Martin Tolar,
CONFERENCE CO-CHAIR
(PARTNERING, LICENSING & ALLIANCE MANAGEMENT SUMMIT)
Pfizer


Jackie Hunter,
KEYNOTE SPEAKER
Senior Vice President Neurology and GI CEDD,
GlaxoSmithKline


Ted Dawson,
KEYNOTE SPEAKER
Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases
Johns Hopkins University School of Medicine


Julie Anderson,
Buck Institute for Age Research


Donna Barton,
Bristol-Myers Squibb


Ella Bossy-Wetzel,
Burnham Institute


Bob Freeman,
University of Rochester School of Medicine


Grant Krafft,
Acumen


David Lowe,
Memory Pharmaceuticals Corporation


Mike O'Neill,
Eli Lilly (UK)


David Park,
University of Ottawa


Serge Przedborski,
Columbia


Rajiv Ratan,
Burke-Cornell Medical Research Institute


Ann Saunders,
GlaxoSmithKline


James Simpkins,
University of North Texas Health Science Center


Inez Vincent,
University of British Colulmbia


Jacqueline Kirchner
Amgen


Ray Bartus
Ceregene


Carol Troy
Columbia University College of Physicians and Surgeons


Mark A. Varney
Cortex Pharmaceuticals


Jack Barber
CytRx


Hsiu-Chiung "Ginnie" Yang
Eli Lilly & Co.


Kalpana Merchant
Eli Lilly & Co.


Jim Wang
EnVivo Pharmaceuticals


Takashi Tsukamoto
MGI Pharma


De-Maw Chuang
National Institute of Mental Health (NIMH)


Jill Heemskerk
National Institute of Neurological Disorders and Stroke


Floyd Bloom
Neurome


Kevin A. Roth
University of Alabama at Birmingham


Peter Reinhart
Wyeth


J. Steven Jacobsen
Wyeth


Diane Stephenson
Pfizer Inc.


Jennifer Johnston
Elan Pharmaceuticals

Venue